Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine
MEDFORD, Mass., Feb. 8 /PRNewswire/ — Biocell Center announced today its further commitment to working with maternal-fetal-medicine doctors by attending the Society for Maternal-Fetal Medicine’s (SMFM) annual meeting.
“Biocell Center has been working with perinatologists and Ob/Gyn doctors worldwide for several years,” said Kate Torchilin, CEO of Biocell Center Corporation. “We understand the effects that high-risk pregnancy can have on mothers and families and we are hoping to inform women undergoing amniocentesis that they have a unique opportunity to cryopreserve amniotic fluid stem cells as a biological insurance for the future.”
Biocell Center Corporation – the only company in the world offering the private preservation of amniotic fluid cells – attended the SMFM meeting in Chicago this week for the first time since it opened for business in the United States in late 2009.
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
SOURCE Biocell Center Corporation